What do systematic reviews say?

Lispro vs regular insulin (Different insulin types within similar insulin regimens)

• Different insulin types and regimens for pregnant women with pre‐existing diabetes 2017 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Lispro vs regular insulin (Different insulin types within similar insulin regimens)

• Different insulin types and regimens for pregnant women with pre‐existing diabetes 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 33 participants
  Very low

Lispro vs regular insulin (Different insulin types within similar insulin regimens)

It is very uncertain whether lispro changes pre‐eclampsia compared with regular insulin (Different insulin types within similar insulin… (very low certainty).

• Different insulin types and regimens for pregnant women with pre‐existing diabetes 2017 · Cochrane Headline outcomes only
  RR 0.68 [0.35, 1.3]
  1 study · 33 participants
  Very low

Lispro vs regular insulin (Different insulin types within similar insulin regimens)

It is very uncertain whether lispro changes caesarean section compared with regular insulin (Different insulin types within similar insulin… (very low certainty).

• Different insulin types and regimens for pregnant women with pre‐existing diabetes 2017 · Cochrane Headline outcomes only
  RR 0.59 [0.25, 1.39]
  1 study · 33 participants
  Very low

Lispro vs regular insulin (Different insulin types within similar insulin regimens)

It is very uncertain whether lispro changes fetal anomaly compared with regular insulin (Different insulin types within similar insulin… (very low certainty).

• Different insulin types and regimens for pregnant women with pre‐existing diabetes 2017 · Cochrane Headline outcomes only
  RR 0.35 [0.02, 8.08]
  1 study · 33 participants
  Very low

Lispro vs regular insulin (Different insulin types within similar insulin regimens)

• Different insulin types and regimens for pregnant women with pre‐existing diabetes 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 33 participants
  Very low

Lispro vs regular insulin (Different insulin types within similar insulin regimens)

• Different insulin types and regimens for pregnant women with pre‐existing diabetes 2017 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Subcutaneous insulin lispro vs intravenous regular insulin

• Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 156 participants
  Moderate

Subcutaneous insulin lispro vs intravenous regular insulin

Subcutaneous insulin lispro showed no clear difference in hypoglycaemic episodes (N) Mean hospital stay: 2‐7 days compared with intravenous regular insulin (low certainty).

• Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
  RR 0.59 [0.23, 1.52]
  4 studies · 156 participants
  Low

Subcutaneous insulin lispro vs intravenous regular insulin

• Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 96 participants
  GRADE not reported
• Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 90 participants
  Low

Subcutaneous insulin lispro vs intravenous regular insulin

The review found no eligible studies for this question.

• Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Subcutaneous insulin lispro vs intravenous regular insulin

• Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 90 participants
  Very low

Subcutaneous insulin lispro vs intravenous regular insulin

The review found no eligible studies for this question.

• Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found